Next Article in Journal
Optimal Use of Bispecific Antibodies for the Treatment of Diffuse Large B-Cell Lymphoma in Canada
Previous Article in Journal
Enhancing Care Through a Virtual Canadian Community of Practice for Managing Immune-Related Adverse Events
 
 
Due to scheduled maintenance work on our servers, there may be short service disruptions on this website between 11:00 and 12:00 CEST on March 28th.
Conference Report

Article Versions Notes

Curr. Oncol. 2025, 32(3), 141; https://doi.org/10.3390/curroncol32030141
Action Date Notes Link
article html file updated 24 June 2025 18:13 CEST Update https://www.mdpi.com/1718-7729/32/3/141/html
article html file updated 27 February 2025 11:13 CET Original file -
article pdf uploaded. 27 February 2025 11:12 CET Version of Record https://www.mdpi.com/1718-7729/32/3/141/pdf
article xml uploaded. 27 February 2025 11:12 CET Update https://www.mdpi.com/1718-7729/32/3/141/xml
article xml file uploaded 27 February 2025 11:12 CET Original file -
Back to TopTop